Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT02241967
Previous Study | Return to List | Next Study

Dose Dependent Effects of tDCS on Post-Operative Pain (tDCS-TKA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02241967
Recruitment Status : Active, not recruiting
First Posted : September 16, 2014
Last Update Posted : October 3, 2019
Sponsor:
Information provided by (Responsible Party):
VA Office of Research and Development

Brief Summary:
The proper control of acute and chronic pain is one of the most important areas in health care. Despite the profound advances in neuroscience over the past 20 years, the investigators still largely use opiate narcotics, much as was done in the Civil War. Total knee arthroplasty (TKA) is one of the most common orthopedic procedures performed 1. While knee pain is often a complaint that precedes TKA, the procedure itself is associated with considerable post-operative pain lasting days to weeks. Adequate postoperative pain control is an important factor in determining recovery time and hospital length of stay. New analgesic strategies are needed that can be used adjunctively to existing strategies with the potential to reduce reliance on opioid analgesia. Several novel brain stimulation technologies including transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) are beginning to demonstrate promise as treatments for a variety of pain conditions. Electricity has no metabolite or other residue, and can be delivered with minimal discomfort and without problems associated with drug-drug interactions. In two independent preliminary pilot studies, the Investigators have shown that tDCS can reduce post-operative PCA use by as much as 46% while simultaneously reducing subjective pain ratings. The present study aims to determine the effects of transcranial direct current stimulation (tDCS) on post-operative pain, patient-controlled analgesia (PCA) use, and post-surgical complications during the 48-hour post-operative period following total knee arthroplasty.

Condition or disease Intervention/treatment Phase
Total Knee Arthroplasty (Postoperative Pain) Total Hip Arthroplasty(Postoperative Pain) Device: Transcranial Direct Current Stimulation Phase 1

Detailed Description:
The proposed study employs a randomized, double-blind, sham-controlled design to evaluate the effects of tDCS on pain among Veterans receiving unilateral total knee arthroplasty (TKA) and unilateral total hip arthroplasty (THA). Further, this study will examine dose-dependency of the tDCS analgesic effects. 120 patients undergoing TKA will be randomly assigned to one of four groups: . Group 1 will have 4 sessions of real tDCS, Group 2 - 2 sessions of real tDCS (+ 2 sham-sessions), and Group 3 - 1 session of real tDCS (+ 3 sham-sessions). Group 4 is "Sham" tDCS, which does not involve any real stimulation. The participants will receive 2 tDCS treatments on the day of their surgery, and 2 tDCS treatments the day after their surgery.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 120 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Dose Dependent Effects of tDCS on Post-Operative Pain
Actual Study Start Date : January 7, 2016
Estimated Primary Completion Date : February 5, 2020
Estimated Study Completion Date : February 5, 2020

Arm Intervention/treatment
Experimental: tDCS Full Dose
4 active treatments
Device: Transcranial Direct Current Stimulation
Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.
Other Name: tDCS

Experimental: tDCS Half Dose
2 active treatments
Device: Transcranial Direct Current Stimulation
Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.
Other Name: tDCS

Experimental: tDCS Minimal dose
1 active treatment
Device: Transcranial Direct Current Stimulation
Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.
Other Name: tDCS

Sham Comparator: Sham tDCS
no active treatments
Device: Transcranial Direct Current Stimulation
Stimulation of brain areas associated with pain perception using low amplitude direct current delivered by electrodes attached to the scalp.
Other Name: tDCS




Primary Outcome Measures :
  1. Post-operative opioid pain medication dose [ Time Frame: 3-Days ]
    Patient Controlled Analgesia pump usage will be measured (mg of morphine-equivalent) during the acute post-operative period.


Secondary Outcome Measures :
  1. Patient-reported pain ratings [ Time Frame: 6 Months ]
    Visual analogue scale pain ratings will be collected during the perioperative and post-discharge periods



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   19 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Participants will be 120 patients undergoing TKA or THA surgery at the Ralph H. Johnson VAMC in Charleston SC.

  • Between the ages of 19 and 90
  • Mentally capable of reading, writing, giving consent, and following instructions
  • Cleared for and scheduled for unilateral TKA or THA surgery

Exclusion Criteria:

  • Implanted medical devices above the waist
  • Pregnant
  • History of seizures
  • Allergic to latex rubber
  • Psychiatric conditions other than for depression and/or anxiety disorders

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02241967


Locations
Layout table for location information
United States, South Carolina
Ralph H. Johnson VA Medical Center, Charleston, SC
Charleston, South Carolina, United States, 29401-5799
Sponsors and Collaborators
VA Office of Research and Development
Investigators
Layout table for investigator information
Principal Investigator: Jeffrey J Borckardt, PhD Ralph H. Johnson VA Medical Center, Charleston, SC

Layout table for additonal information
Responsible Party: VA Office of Research and Development
ClinicalTrials.gov Identifier: NCT02241967     History of Changes
Other Study ID Numbers: CLIN-005-13F
CX001078 ( Other Grant/Funding Number: Charleston CSR&D )
First Posted: September 16, 2014    Key Record Dates
Last Update Posted: October 3, 2019
Last Verified: October 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: No
Keywords provided by VA Office of Research and Development:
total knee arthroplasty
pain
post-surgical pain
opioid
transcranial direct current stimulation
tDCS
brain stimulation
total hip arthroplasty
TKA
THA
Additional relevant MeSH terms:
Layout table for MeSH terms
Pain, Postoperative
Postoperative Complications
Pathologic Processes
Pain
Neurologic Manifestations
Signs and Symptoms